RiskOn International And 3 Other Stocks Under $2 Insiders Are Buying

RiskOn International和其他3只2美元以下的股票內部人士正在買入

Benzinga · 2023/12/11 21:34

The Dow Jones closed higher by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Forte Biosciences

The Trade: Forte Biosciences, Inc. (NASDAQ:FBRX) Director Paul A Wagner acquired a total of 51,203 shares an average price of $0.60. To acquire these shares, it cost around $30,468.
What's Happening: On Nov. 13, Forte Biosciences posted a wider third-quarter loss.
What Forte Biosciences Does: Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease ("GvHD"), vitiligo and alopecia areata ("AA").

CommScope Holding

The Trade: CommScope Holding Company, Inc. (NASDAQ:COMM) SVP & President, CCS Koen Linde Ter acquired a total of 13,513 shares at an average price of $1.84. To acquire these shares, it cost around $24,857.
What's Happening: On Nov. 9, CommScope reported third-quarter net sales of $1.6 billion.
What CommScope Holding Does: CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center and entertainment networks.

Check This Out: How To Earn $500 A Month From Dollar General Stock After Upbeat Earnings

RiskOn International

The Trade: RiskOn International, Inc. (NASDAQ:ROI) 10% owner Milton C. Ault III acquired a total of 2,000 shares at an average price of $0.21. The insider spent around $416 to buy those shares.
What's Happening: On Dec. 4, RiskOn International announced Kurt Flygare has been named Chief Executive Officer of GuyCare Management, Inc., a subsidiary of GuyCare, Inc.
What RiskOn International Does: RiskOn International Inc is a holding company which owns BitNile metaverse platform that allows users to engage with a new social networking community and purchase both digital and physical products while playing 3D immersive games.

Erasca

The Trade: Erasca, Inc. (NASDAQ:ERAS) Director Harding Denise Valerie Start acquired a total of 10,000 shares at an average price of $1.85. The insider spent around $18,480 to buy those shares.
What's Happening: On Nov. 9, Erasca posted a narrower-than-expected quarterly loss.
What Erasca Does: Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

Don't forget to check out our premarket coverage here

The Dow Jones closed higher by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道瓊斯指數週五收盤上漲超過100點。當內部人士購買或賣出股票時，這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將其視爲其整體投資或交易決策中的一個因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是近期一些值得注意的細價股內幕交易。欲了解更多，請查看 本辛加的內幕交易 平台。

Forte Biosciences

Forte 生物科學

The Trade: Forte Biosciences, Inc. (NASDAQ:FBRX) Director Paul A Wagner acquired a total of 51,203 shares an average price of $0.60. To acquire these shares, it cost around $30,468.
What's Happening: On Nov. 13, Forte Biosciences posted a wider third-quarter loss.
What Forte Biosciences Does: Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease ("GvHD"), vitiligo and alopecia areata ("AA").

交易：Forte Biosciences, Inc.（納斯達克股票代碼：FBRX）董事保羅·瓦格納 共收購了 51,203 股股票 平均價格爲0.60美元。收購這些股票的成本約爲30,468美元。
發生了什麼：11月13日，Forte Biosciences公佈了更大的第三季度虧損。
Forte Biosciences的所作所爲：Forte Biosciences Inc是一家生物製藥公司，正在通過臨床前試驗推進其候選產品 FB-102，這是一種專有的治療分子，在移植物抗宿主病（“gvHD”）、白癜風和脫髮（“AA”）等適應症中具有廣泛的自身免疫應用。

CommScope Holding

康普控股

The Trade: CommScope Holding Company, Inc. (NASDAQ:COMM) SVP & President, CCS Koen Linde Ter acquired a total of 13,513 shares at an average price of $1.84. To acquire these shares, it cost around $24,857.
What's Happening: On Nov. 9, CommScope reported third-quarter net sales of $1.6 billion.
What CommScope Holding Does: CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center and entertainment networks.

交易：康普控股公司（納斯達克股票代碼：COMM）高級副總裁兼CCS總裁 Koen Linde Ter 共收購了13,513股股票 平均價格爲1.84美元。收購這些股票的成本約爲24,857美元。
發生了什麼：11月9日，康普公佈第三季度淨銷售額爲16億美元。
康普控股公司做什麼：康普控股公司是通信、數據中心和娛樂網絡基礎設施解決方案的提供商。

Check This Out: How To Earn $500 A Month From Dollar General Stock After Upbeat Earnings

看看這個： 收益樂觀後，如何每月從美元普通股中賺取500美元

RiskOn International

RiskOn 國際

The Trade: RiskOn International, Inc. (NASDAQ:ROI) 10% owner Milton C. Ault III acquired a total of 2,000 shares at an average price of $0.21. The insider spent around $416 to buy those shares.
What's Happening: On Dec. 4, RiskOn International announced Kurt Flygare has been named Chief Executive Officer of GuyCare Management, Inc., a subsidiary of GuyCare, Inc.
What RiskOn International Does: RiskOn International Inc is a holding company which owns BitNile metaverse platform that allows users to engage with a new social networking community and purchase both digital and physical products while playing 3D immersive games.

The Trade：RiskOn International, Inc.（納斯達克股票代碼：ROI）10% 的所有者 Milton C. 共收購了 2,000 股股份 平均價格爲0.21美元。知情人花了大約416美元購買這些股票。
發生了什麼：12月4日，RiskOn International宣佈，Kurt Flygare被任命爲GuyCare, Inc.的子公司GuyCare Management, Inc. 的首席執行官。
RiskOn International 做什麼：RiskOn International Inc. 是一家控股公司，擁有 BitNile 元宇宙平台，該平台允許用戶在玩 3D 沉浸式遊戲的同時參與新的社交網絡社區併購買數字和實體產品。

Erasca

埃拉斯卡

The Trade: Erasca, Inc. (NASDAQ:ERAS) Director Harding Denise Valerie Start acquired a total of 10,000 shares at an average price of $1.85. The insider spent around $18,480 to buy those shares.
What's Happening: On Nov. 9, Erasca posted a narrower-than-expected quarterly loss.
What Erasca Does: Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

The Trade：Erasca, Inc.（納斯達克股票代碼：ERAS）董事哈丁·丹妮絲·瓦萊麗·斯塔特 共收購了 10,000 股股票 平均價格爲1.85美元。內幕人士花費了大約18,480美元購買了這些股票。
發生了什麼：11月9日，埃拉斯卡公佈的季度虧損低於預期。
Erasca做什麼：Erasca Inc是一家臨床階段的精準腫瘤學公司，專門致力於爲RAS/MAPK路徑驅動的癌症患者發現、開發和商業化療法。

Don't forget to check out our premarket coverage here

別忘了在這裏查看我們的上市前報道

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。